The WACC of Winshine Science Co Ltd (209.HK) is 7.7%.
Range | Selected | |
Cost of equity | 12.70% - 37.80% | 25.25% |
Tax rate | 6.20% - 14.80% | 10.50% |
Cost of debt | 5.90% - 7.00% | 6.45% |
WACC | 6.3% - 9.2% | 7.7% |
Category | Low | High |
Long-term bond rate | 2.9% | 3.4% |
Equity market risk premium | 6.0% | 7.0% |
Adjusted beta | 1.64 | 4.86 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 12.70% | 37.80% |
Tax rate | 6.20% | 14.80% |
Debt/Equity ratio | 8.98 | 8.98 |
Cost of debt | 5.90% | 7.00% |
After-tax WACC | 6.3% | 9.2% |
Selected WACC | 7.7% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 209.HK:
cost_of_equity (25.25%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (1.64) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.